Parallel Advisors, LLC - HALOZYME THERAPEUTICS INC ownership

HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 384 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.1%.

Quarter-by-quarter ownership
Parallel Advisors, LLC ownership history of HALOZYME THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$16,808
+71.3%
440
+61.8%
0.00%
Q2 2023$9,811
+94.6%
272
+106.1%
0.00%
Q1 2023$5,041
-42.8%
132
-14.8%
0.00%
Q4 2022$8,820
-19.8%
155
-44.2%
0.00%
-100.0%
Q3 2022$11,000
+22.2%
278
+42.6%
0.00%
Q2 2022$9,000
+50.0%
195
+25.0%
0.00%
Q1 2022$6,0000.0%156
+12.2%
0.00%
Q4 2021$6,000
-57.1%
139
-59.9%
0.00%
-100.0%
Q3 2021$14,000
+250.0%
347
+273.1%
0.00%
Q2 2021$4,000
-33.3%
93
-38.8%
0.00%
Q1 2021$6,000
+50.0%
152
+63.4%
0.00%
Q4 2020$4,000
-42.9%
93
-65.3%
0.00%
Q3 2020$7,0000.0%2680.0%0.00%
Q2 2020$7,000
+133.3%
268
+45.7%
0.00%
Q1 2020$3,0000.0%184
+5.1%
0.00%
Q4 2019$3,0000.0%1750.0%0.00%
Q3 2019$3,0000.0%1750.0%0.00%
Q2 2019$3,0001750.00%
Other shareholders
HALOZYME THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Third Security, LLC 19,829,337$266,308,00010.60%
BB BIOTECH AG 6,929,832$93,068,0002.95%
SECTORAL ASSET MANAGEMENT INC 2,671,051$35,872,0001.64%
Sterling Global Strategies LLC 22,000$295,0001.63%
Lombard Odier Asset Management (USA) Corp 1,061,547$14,257,0001.24%
PYRRHO CAPITAL MANAGEMENT, LP 90,000$1,209,0001.04%
IRIDIAN ASSET MANAGEMENT LLC/CT 8,184,003$109,911,0000.93%
Bellevue Asset Management AG 246,000$3,304,0000.54%
Convergence Investment Partners, LLC 251,748$3,381,0000.39%
Rhenman & Partners Asset Management AB 172,000$2,310,0000.37%
View complete list of HALOZYME THERAPEUTICS INC shareholders